Cecile Lefebvre

Université Paris Est Créteil, INSERM U955, Team Lévy
Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

SARS-CoV-2 mRNA XBB1.5 vaccine immunogenicity in kidney transplant recipients.

SARS-CoV-2 mRNA XBB1.5 vaccine immunogenicity in kidney transplant recipients.

Journal: Virology journal

Published: February 06, 2026

Transcriptomic analysis of chronic chikungunya in the Reunionese CHIKGene cohort uncovers a shift in gene expression more than 10 years after infection.

Transcriptomic analysis of chronic chikungunya in the Reunionese CHIKGene cohort uncovers a shift in gene expression more than 10 years after infection.

Journal: Travel medicine and infectious disease

Published: October 18, 2024

An oral carbon monoxide-releasing molecule protects against acute hyperhemolysis in sickle cell disease.

An oral carbon monoxide-releasing molecule protects against acute hyperhemolysis in sickle cell disease.

Journal: Blood

Published: November 08, 2023

A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease.

A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease.

Journal: Cell reports. Medicine

Published: October 06, 2023

Critical contribution of mitochondria in the development of cardiomyopathy linked to desmin mutation.

Critical contribution of mitochondria in the development of cardiomyopathy linked to desmin mutation.

Journal: Stem cell research & therapy

Published: October 03, 2023

Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo.

Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo.

Journal: Cell reports

Published: April 11, 2023

Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19.

Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19.

Journal: Journal of clinical immunology

Published: March 29, 2023

Erratum: CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.

Erratum: CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.

Journal: iScience

Published: January 02, 2023

Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.

Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.

Journal: Journal of clinical immunology

Published: December 23, 2022

T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial.

T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: November 17, 2021

CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.

CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.

Journal: iScience

Published: February 08, 2021

Ultrafast Hypothermia Selectively Mitigates the Early Humoral Response After Cardiac Arrest.

Ultrafast Hypothermia Selectively Mitigates the Early Humoral Response After Cardiac Arrest.

Journal: Journal of the American Heart Association

Published: November 17, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026